Australia Stock Exchange release from ANATARA LIFESCIE : Appendix 4C & Q1 FY22 Activities Report
Australia Stock Exchange release from ANATARA LIFESCIE ANR.AX : Appendix 4C & Q1 FY22 Activities Report
Recent news on Anatara Lifesciences
See all newsAustralia's Anatara Lifesciences falls on discounted placement
Brief: Anatara Lifesciences Receives Firm Commitments For A$1.2M Placement
Brief: Anatara Lifesciences Seeks Trading Halt
Brief: Anatara Lifesciences Says Hong Kong Patent Granted For GARP Product
Brief: Anatara Lifesciences Seeks Trading Halt Pending Announcement Regarding Update On Phase II Garp-Ibs Trial